Whether ERK3 contributes to tumorigenesis in melanoma expressing BRafV600E remains elusive because depletion of ERK3 in A375 cells did not change tumour cell proliferation, apoptosis or angiogenesis in mice injected with A375 cells stably transfected with ERK3 shRNA [60]. This evidence concerns the gene MAPK6 and melanoma.